COVID-19

Crucial test to identify those who have recovered from COVID-19 and have active immunity

04/04/2020

Excerpt from the article: “A test that can determine if a patient had been infected and recovered from COVID-19 is being developed at Mayo Clinic Laboratories. The test will detect the presence of antibodies specific to SARS-CoV-2, the virus that causes COVID-19. Antibodies are produced by a person’s immune system, and are critical for control…

Read More

Researchers to study if startup’s wrist-worn wearable can detect early COVID-19 respiratory issues

04/03/2020

Excerpt from the article: “It’s highly unlikely that the current coronavirus crisis will be neatly and fully “solved” by any one endeavor or solution, which makes new studies like one involving startup WHOOP’s wrist-worn fitness and health tracking wearable all the more important. The study, conducted by the Central Queensland University Australia (CQUniversity), in partnership…

Read More

FDA authorizes Bodysphere 2-minute COVID-19 test

04/03/2020

Excerpt from the article: “Bodysphere announced today that it has begun distributing its 2-minute testing kit for diagnosing COVID-19 after receiving FDA emergency use authorization (EUA). The Los Angeles-based company’s two-minute testing kit uses antibodies in blood to test for current or past infection with a 91% clinical specificity rate and a 99% clinical sensitivity…

Read More

The impact of COVID-19 on biotech/pharma service providers.

04/02/2020

The Team at Zymewire took advantage of their unique position in the life sciences space to survey their client base regarding the impact of COVID-19 on their operations and business outlook. TrialStat had an opportunity to participate in the survey and the results are out. It’s resoundingly clear that the pandemic is impacting all aspects…

Read More

How innovation communities — around the world — are banding together to fight COVID-19

04/01/2020

Excerpt from the article: “It — somehow — hasn’t even been three months since the novel coronavirus was first identified, after dozens of people fell ill in Wuhan, China. But in that short time, scientists and researchers have worked at warp speed to understand the disease it causes: Already, nearly 30,000 studies have been conducted…

Read More

‘We’re racing against the clock’: Researchers test wearables as an early warning system for Covid-19

03/29/2020

Excerpt from the article: “Researchers at two prominent California universities launched ambitious new studies this week to test whether wearables can serve as a sort of early-warning system for parts of the country not yet flooded with coronavirus cases. University of California, San Francisco, researchers are exploring whether an algorithm fed with data from Oura…

Read More

Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits

03/26/2020

Excerpt from the article: By Laurie Halloran, CEO & Chairwoman of the Board, Halloran Consulting Group, Inc. While we have not yet seen any significant delays in regulatory approval of life science products to date, the impact of COVID-19 on global health authorities is continuing to evolve. We expect a variety of potential delays in…

Read More

The state of COVID-19 testing

03/26/2020

Excerpt from the article: “In these unprecedented times, we know that controlling the spread of novel coronavirus requires social distancing and testing. While all of us are doing our parts to stay at home, there’s a lot of confusion, chaos and frustration surrounding coronavirus testing in the US.  Before going further, I want to be…

Read More

AI shows high accuracy for detecting COVID-19 on CT

03/25/2020

Excerpt from the Article: A newly developed artificial intelligence (AI)-based system is highly accurate for detecting the novel coronavirus disease (COVID-19) on thoracic CT studies, according to research published online March 13 on arXiv.org. It can also quantify and track disease burden. Click the button below to read the entire article: Continue Reading The Article

Read More

AI differentiates COVID-19 from other pneumonia

03/25/2020

Excerpt from the article: “Researchers from China have developed an artificial intelligence (AI) algorithm that accurately detects COVID-19 and differentiates it from community-acquired pneumonia and other lung diseases. They shared their results in an article published online March 19 in Radiology.” Click the button below to read the entire article! Continue To The Article

Read More